Humoral Immunity to Viruses

  • Neil R. Cooper


Viruses are the causative agents of a number of acute and chronic infectious diseases and are undoubtedly involved in the pathogenesis of certain chronic debilitating diseases of man. Furthermore, a number of viruses may become latent in cells and reemerge at a later time to produce disease. It is therefore not surprising that vertebrates have evolved a multitude of defense mechanisms, operative at multiple levels, to cope with the omnipresent threat posed by viruses. These defenses range from simple physical barriers to sophisticated, complex systems such as the finely tuned interacting members of the immunological network. Disease may result not only from a failure of primary or secondary defense mechanisms but also in some cases from overzealous efforts of the host to cope with the viruses.


Newcastle Disease Virus Humoral Immunity Classical Pathway Complement Protein Rubella Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adler, F. L., Walker, W. S., and Fishman, M., 1971, Amplification of phage neutralization by complement, antiglobulin and anti-allotype sera, Virology 46: 797.PubMedGoogle Scholar
  2. Akiyama, Y., and Inoue, K., 1977, Isolation and properties of complement-resistant strains of Escherichia coli K-12, Infect. Immun. 18: 446.PubMedGoogle Scholar
  3. Almeida, J. D., and Laurence, G. D., 1969, Heated and unheated antiserum on rubella virus, Am. J. Dis. Child. 118: 101.PubMedGoogle Scholar
  4. Almeida, J. D., and Waterson, A. P., 1969, The morphology of virus-antibody interaction, Adv. Virus Res. 15: 307.PubMedGoogle Scholar
  5. Almeida, J., Cinader, B., and Howatson, A., 1963, The structure of antigen-antibody complexes: A study of electron microscopy, J.Exp. Med. 118: 327.PubMedGoogle Scholar
  6. Almeida, J. D., Brown, F., and Waterson, A. P., 1967, The morphologic characteristics of 19 S antibody, J. Immunol. 98: 186.PubMedGoogle Scholar
  7. Alving, C. R., Joseph, K. C., and Wistar, R., 1974, Influence of membrane composition on the interaction of a human monoclonal “anti-Forssman” immunoglobulin with liposomes, Biochemistry 13: 4818.PubMedGoogle Scholar
  8. Aoki, T., Liu, M., Walling, M. J., Bushar, G. S., Brandchaft, P. B., and Kawakami, T. G., 1976, Specificity of naturally occurring antibody in normal gibbon serum, Science 191: 1180.PubMedGoogle Scholar
  9. Apostolov, K., and Sawa, M. I., 1976, Enhancement of haemolysis of Newcastle disease virus (NDV) after pre-treatment with heterophile antibody and complement, J. Gen. Virol. 33: 459.PubMedGoogle Scholar
  10. Bang, F. B., Foard, M., and Karzon, D. T., 1950, The determination and significance of substances neutralizing Newcastle virus in human serum, Bull. Johns Hopkins Hosp. 87: 130.PubMedGoogle Scholar
  11. Bartholomew, R. M., and Esser, A. F., 1978, Differences in activation of human and guinea pig complement by retroviruses, J. Immunol. 121: 1748.PubMedGoogle Scholar
  12. Bartholomew, R. M., Esser, A. F., and Miiller-Eberhard, H. J., 1978, Lysis of oncornaviruses by human serum: Isolation of the viral complement (CI) receptor and identification as pl5E, J. Exp. Med. 147: 844.PubMedGoogle Scholar
  13. Bendinelli, M., Nardini, L., and Campa, M., 1974, Neutralization of Friend leukemia virus by sera of unimmunized animals, J. Gen. Virol. 22: 207.PubMedGoogle Scholar
  14. Berry, D. M., and Almeida, J. D., 1968, The morphological and biological effects of various antisera on avian infectious bronchitis virus, J. Gen. Virol. 3: 97.PubMedGoogle Scholar
  15. Best, J. M., Banatvala, J. E., Almeida, J. D., and Waterson, A. P., 1967, Morphological characteristics of rubella virus, Lancet 2: 237.Google Scholar
  16. Borsos, T., Dourmashkin, R. R., and Humphrey, J. H., 1964, Lesions in erythrocyte membranes caused by immune haemolysis, Nature (London) 202: 251.Google Scholar
  17. Charman, H. P., Kim, N., White, M., Marquardt, H., Gilden, R. V., and Kawakami, T., 1975, Natural and experimentally induced antibodies to defined mammalian type-C virus proteins in primates, J. Natl. Cancer Inst. 55: 1419.PubMedGoogle Scholar
  18. Cooper, N. R., and Ziccardi, R. J., 1976, The nature and reactions of complement enzymes, in: Proteolysis and Physiological Regulation, Vol. 11 ( D. W. Ribbons and K. Brew, eds.), p. 167, Academic Press, New York.Google Scholar
  19. Cooper, N. R., and Ziccardi, R. J., 1977, Reconstitution of CI in native, proenzyme form and its use in a quantitative CI activation test, Immunol. 119: 1664.Google Scholar
  20. Cooper, N. R., Jensen, F. C., Welsh, Jr., R. M., and Oldstone, M. B. A., 1976, Lysis of RNA tumor viruses by human serum: Direct antibody independent triggering of the classical complement pathway, J. Exp. Med. 144: 970.PubMedGoogle Scholar
  21. Dahl, J. S., Hellewell, S. B., and Levine, R. P., 1977, A mycoplasma mutant resistant to lysis by C: Variations in membrane composition and altered response to the terminal C complex,J. Immunol. 119: 1419.Google Scholar
  22. Dales, S., 1965, Penetration of animal viruses into cells, Prog. Med. Virol. 7: 1.PubMedGoogle Scholar
  23. Daniels, C. A., 1975, Mechanism of virus neutralization, in: Viral Immunology and Immunopathology ( A. L. Notkins, ed.), p. 79, Academic Press, New York.Google Scholar
  24. Daniels, C. A., Borsos, T., Snyderman, R., and Notkins, A. L., 1969, Neutralization of sensitized virus by the fourth component of complement, Science 165: 508.PubMedGoogle Scholar
  25. Daniels, C. A., Borsos, T., Rapp, H. J., Snyderman, R., and Notkins, A. L., 1970, Neutralization of sensitized virus by purified components of complement, Proc. Natl. Acad. Sci. USA 65: 528.PubMedGoogle Scholar
  26. Day, N. K., and Good, R. A., eds., 1977, Biological Amplification Systems in Immunology (Comprehensive Immunology, Vol. 2 ), Plenum Press, New York.Google Scholar
  27. Dozois, T. F., Wagner, J. C., Chemerda, C. M., and Andrew, V. M., 1949, The influence of certain serum factors of the neutralization of western equine encephalomyelitis virus, J. Immunol. 62: 319.PubMedGoogle Scholar
  28. Dulbecco, R., Vogt, M., and Strickland, A. G. R., 1956, A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus, Virology 2: 162.PubMedGoogle Scholar
  29. Fazekas de St. Groth, S., 1962, The neutralization of viruses, Adv. Virus Res. 9: 1.Google Scholar
  30. Fenner, F., McAuslan, B. R., Mims, C. A., Sambrook, J., and White, D. O., 1974, The Biology of Animal Viruses, 2nd ed., Academic Press, New York.Google Scholar
  31. Fischinger, P. J., Ihle, J. N., Bolognesi, D. P., and Schäfer, W., 1976, Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin- mediated, Virology 11: 346.Google Scholar
  32. Frank, M. M., May, J., Gaither, T., and Ellman, L., 1971, In vitro studies of complement function in sera of C4-deficient guinea pigs, J. Exp. Med. 134: 176.PubMedGoogle Scholar
  33. Gallagher, R. E., Schrecker, A. W., Walter, C. A., and Gallo, R. C., 1978, Oncornavirus lytic activity in the serum of gibbon apes, J. Natl. Cancer Inst. 60: 677.PubMedGoogle Scholar
  34. Gallo, R. C., Gallagher, R. E., Wong-Staal, F., Aoki, T., Markham, P. D., Schetters, H., Ruscetti, F., Valerio, M., Walling, M. J., O’Keeffe, R. T., Saxinger, W. C., Smith, R. G., Gillespie, D. H., and Reitz, M. S., Jr., 1978, Isolation and tissue distribution of type-C virus and viral components from a gibbon ape (Hylobates lar) with lymphocytic leukemia, Virology 84: 359.PubMedGoogle Scholar
  35. Gewürz, H., Shin, H. S., and Mergenhagen, S. E., 1968, Interactions of the complement system with endotoxic lipopolysaccharide: Consumption of each of the six terminal complement compounds, J. Exp. Med. 128: 1049.PubMedGoogle Scholar
  36. Ginsberg, H. S., and Horsfall, F. L., 1949, A labile component of normal serum which combines with various viruses: Neutralization of infectivity and inhibition of hemagglutination by the component, J. Exp. Med. 90: 475.PubMedGoogle Scholar
  37. Gordon, M. H., 1925, Studies of the viruses of vaccinia and variola, Spec. Rep. Ser. Med. Res. Counc. G. B., No. 98.Google Scholar
  38. Götze, O., and Müller-Eberhard, H. J., 1971, The activator system: An alternate pathway of complement activation, J. Exp. Med. 134: 90s.Google Scholar
  39. Götze, O., and Müller-Eberhard, H. J., 1976, The alternative pathway of complement activation, Adv. Immunol. 24: 1.PubMedGoogle Scholar
  40. Granoff, A., 1965, The interaction of Newcastle disease virus and neutralizing antibody, Virology 25: 38.PubMedGoogle Scholar
  41. Hampar, B., Notkins, A. L., Mage, M., and Keehn, M. A., 1968, Heterogeneity in the properties of 7 S and 19 S rabbit-neutralizing antibodies to herpes simplex virus, J. Immunol. 100: 586.PubMedGoogle Scholar
  42. Haukenes, G., 1977, Demonstration of host antigens in the myxovirus membrane: Lysis of virus by antibody and complement, Acta Pathol. Microbiol. Scand. Sect. B 85: 125.Google Scholar
  43. Heberling, R. L., Barker, S. T., Kalter, S. S., Smith, G. C., and Helmke, R. J., 1977, Oncornavirus: Isolation from a squirrel monkey (Saimiri sciureus) lung culture, Science 195: 289.PubMedGoogle Scholar
  44. Heineman, H. S., 1969, Herpes simplex neutralizing antibody Quantitation of the complement dependent fraction in different phases of adult human infection, J. Immunol. 99: 214.Google Scholar
  45. Hersch, E. M., Hanna, M. G., Jr., Gutterman, J. V., Mavligit, G., Yurconic, M., Jr., and Gschwind, C. R., 1974, Human immune response to active immunization with Rauscher leukemia virus. II. Humoral immunity, J. Natl. Cancer Inst. 53: 327.Google Scholar
  46. Howitt, B. F., 1950, A nonspecific heat-labile factor in the serum neutralization test for Newcastle disease virus, J. Immunol. 64: 73.Google Scholar
  47. Hugli, T. E., and Müller-Eberhard, H. J., 1978, Anaphylatoxins: C3a and C5a, Adv. Immunol. 26: 1.PubMedGoogle Scholar
  48. Hummeler, K., and Ketler, A., 1958, Dissociation of poliomyelitis virus from neutralizing antibody, Virology 6: 297.PubMedGoogle Scholar
  49. Hummeler, K., Anderson, T. F., and Brown, R. A., 1962, Identification of poliovirus particles of different antigenicity by specific agglutination as seen in the electron microscope, Virology 16: 84.PubMedGoogle Scholar
  50. Humphrey, J. H., Dourmashkin, R. R., and Payne, S. N., 1967, The nature of lesions in cell membranes produced by action of C and antibody, in: Immunopathology, V International Symposium ( P. A. Miescher and P. Grabar, eds.), p. 209, Grune and Stratton, New York.Google Scholar
  51. Inoue, K., Kataoka, T., and Kinsky, S. C., 1971, Comparative responses of liposomes prepared with different ceramide antigens to antibody and complement, Biochemistry 10: 2574.PubMedGoogle Scholar
  52. Jensen, F. C., Welsh, R. M., Cooper, N. R., and Oldstone, M. B. A, 1976, Lysis of oncornaviruses by human serum, Comp. Leuk. Res. Bibl. Haematol. 43: 438.Google Scholar
  53. Joseph, B. S., Lampert, P. W., and Oldstone, M. B. A., 1975, Replication and persistence of measles virus in defined subpopulations of human leukocytes, J. Virol. 16: 1638.PubMedGoogle Scholar
  54. Katz, D. H., 1977, Lymphocyte Differentiation, Recognition and Regulation, Academic Press, New York.Google Scholar
  55. Kawakami, T. G., Huff, S. D., Buckley, P. M., Dungworth, D. L., Snyder, S. P., and Gilden, R. V., 1972, C-type virus associated with gibbon lymphosarcoma, Nature tLondon) New Biol. 235: 170.Google Scholar
  56. Keller, R., 1968, Studies on the mechanism of the enzymatic reactivation of antibody neutralized poliovirus, J. Immunol. 100: 1071.PubMedGoogle Scholar
  57. Klenk, H.-D., Rott, R., and Becht, H., 1972, On the structure of the influenza virus envelope, Virology 47: 579.PubMedGoogle Scholar
  58. Lachmann, P. J., and Rosen, F. S., 1978, Genetic defects of complement in man, in: Springer Seminars in Immunopathology, Vol. 1 ( P. A. Miescher and H. J. Miiller- Eberhard, eds.), p. 339, Springer-Verlag, New York.Google Scholar
  59. Lafferty, K. J., 1963, The interaction between virus and antibody. II. Mechanism of the reaction, Virology 21: 76.PubMedGoogle Scholar
  60. Lafferty, K. J., and Oertelis, S., 1963, The interaction between virus and antibody. III. Examination of virus-antibody complexes with the electron microscope, Virology 21: 91.Google Scholar
  61. Laver, W. G., and Webster, R. G., 1966, The structure of influenza viruses. IV. Chemical studies of the host antigen, Virology 30: 104.PubMedGoogle Scholar
  62. Leddy, J. P., Simons, R. L., and Douglas, R. G., 1977, Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera, J. Immunol. 118: 28.PubMedGoogle Scholar
  63. Leong, J. C., Kane, J. P., Oleszko, O., and Levy, J. A., 1977, Antigen specific nonim munoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins, Proc. Natl. Acad. Sci. USA 74: 276.Google Scholar
  64. Levy, J. A., Ihle, J. N., Oleszko, O., and Barnes, R. D., 1975, Virus specific neutralization by a soluble non immunoglobulin factor found naturally in normal mouse sera, Proc. Natl. Acad. Sci. USA 72: 5071.PubMedGoogle Scholar
  65. Leymaster, G. R., and Ward, T. G., 1949, The effect of complement in the neutralization of mumps virus, J. Immunol. 61: 95.PubMedGoogle Scholar
  66. Linscott, W. D., and Levinson, W. E., 1969, Complement components required for virus neutralization by early immunoglobulin antibody, Proc. Natl. Acad. Sci. USA 64: 520.PubMedGoogle Scholar
  67. Marcus, R. L., Shin, H. S., and Mayer, M. M., 1971, An alternate complement pathway: C-3 cleaving activity, not due to C4,2a, on endotoxic lipopolysaccharide after treatment with guinea pig serum; relation to properdin, Proc. Natl. Acad. Sci. USA 68: 1351.PubMedGoogle Scholar
  68. Mayer, M., 1976, The Nature and Significance of Complement Activation (W. Pollack, ed.), Ortho Research Institute, International Symposium, Raritan, N.J.Google Scholar
  69. McCarthy, K., and Germer, W. D., 1952, Two heat-labile factors in normal sera which neutralize variola virus, Br. J. Exp. Pathol. 33: 529.PubMedGoogle Scholar
  70. Mills, B. J., and Cooper, N. R., 1978a, Analysis of the mechanism of VSV inactivation by human serum, J. Immunol. 120: 1786.Google Scholar
  71. Mills, B. J., and Cooper, N. R., 1978£, Antibody-independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements, J. Immunol. 121: 1549.Google Scholar
  72. Mueller, J. H., 1931, The effect of alexin in virus-antivirus mixtures, J. Immunol. 20: 17.Google Scholar
  73. Miiller-Eberhard, H. J., 1975, Complement, Annu. Rev. Biochem. 44: 697.PubMedGoogle Scholar
  74. Nelson, R. A., 1958, An alternative mechanism for the properdin system, J. Exp. Med. 108: 515.PubMedGoogle Scholar
  75. Neva, F. A., and Weller, T. H., 1964, Rubella, interferon and factors influencing the indirect neutralization test for rubella antibody, J. Immunol. 93: 466.PubMedGoogle Scholar
  76. Notkins, A., 1975, Viral Immunology and Immunopathology, Academic Press, New York.Google Scholar
  77. Notkins, A. L., Mergenhagen, S. E., and Howard, R. J., 1970, Effect of virus infections on the function of the immune system, Annu. Rev. Microbiol. 24: 525.PubMedGoogle Scholar
  78. Notkins, A. L., Rosenthal, J., and Johnson, B., 1971, Rate-zonal centrifugation of herpes simplex virus-antibody complexes, Virology 43: 321.PubMedGoogle Scholar
  79. Oldstone, M. B. A., 1975, Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury-two sides of the same coin, Prog. Med. Virol. 19: 84.PubMedGoogle Scholar
  80. Oldstone, M. B. A., 1975, Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury-two sides of the same coin, Prog. Med. Virol. 19: 84.PubMedGoogle Scholar
  81. Oldstone, M. B. A., Cooper, N. R., and Larson, D. L., 1974, Formation and biologic role of polyoma virus-antibody complexes, J. Exp. Med. 140: 549.PubMedGoogle Scholar
  82. Orozlan, S., and Gilden, R. V., 1970, Immune virolysis: Effect of antibody and complement on C-type RNA virus, Science 168: 1478.Google Scholar
  83. Osier, A. G., 1976, Foundations of Immunology Series, Prentice-Hall, Englewood Cliffs, N.J.Google Scholar
  84. Osier, A. G., and Sandberg, A. L., 1973, Alternate complement pathways, Prog. Allergy 17: 51.Google Scholar
  85. Ozaki, Y., and Tabeyi, K., 1967, Studies on the neutralization of Japanese encephalitis virus. I. Application of kinetic neutralization to the measurement of the neutralizing potency of antiserum, J. Immunol. 98: 1218.PubMedGoogle Scholar
  86. Parkman, P. D., Mundon, F. K., McCowan, J. M., and Buescher, E. L., 1964, Studies of rubella. II. Neutralization of the virus, J. Immunol. 93: 608.PubMedGoogle Scholar
  87. Perrin, L. H., Joseph, B. S., Cooper, N. R., and Oldstone, M. B. A., 1976, Mechanism of injury of virus infected cells by antiviral antibody and complement: Participation of IgG, Fab’2 and the alternative complement pathway, J. Exp. Med. 143: 1027.PubMedGoogle Scholar
  88. Pillemer, L., Blum, L., Lepow, I. H., Ross, O. A., Todd, E. W., and Wardlaw, A. C., 1954, The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena, Science 120: 279.PubMedGoogle Scholar
  89. Radwan, A. I., and Burger, D., 1973, The complement-requiring neutralization of equine arteritis virus by late antisera, Virology 51: 71.PubMedGoogle Scholar
  90. Radwan, A. I., and Crawford, T. B., 1974, The mechanisms of neutralization of sensitized equine arteritis virus by complement components, J. Gen. Virol. 25: 229.PubMedGoogle Scholar
  91. Radwan, A. I., Burger, D., and Davis, W. C., 1973, The fate of sensitized equine arteritis virus following neutralization by complement or anti IgG serum, Virology 53: 372.PubMedGoogle Scholar
  92. Rawls, W., and Tompkins, W., 1975, Destruction of virus infected cells by antibody and complement, in: Viral Immunology and Immunopathology ( A. Notkins, ed.), p. 99, Academic Press, New York.Google Scholar
  93. Rawls, W. E., Desmyter, J., and Melnick, J. L., 1967, Rubella virus neutralization by plaque reduction, Proc. Soc. Exp. Biol. Med. 124: 167.Google Scholar
  94. Reid, K. B. M., and Porter, R. R., 1975, The structure and mechanism of activation of the first component of complement, in: Contemporary Topics in Molecular Immunology, Vol. 4 ( F. P. Inman and W. J. Mandy, eds.), p. 1, Plenum Press, New York.Google Scholar
  95. Rott, R., Drzeniek, R., Saber, M. S., and Reichert, E., 1966, Blood group substances, Forssman and mononucleosis antigens in lipid-containing RNA viruses, Arch. Gesamte Virusforsch. 19: 273.Google Scholar
  96. Sabin, A., 1950, The dengue group of viruses and its family relationships, Bacteriol. Rev. 14: 225.PubMedGoogle Scholar
  97. Sandberg, A. L., Osier, A. G., Shin, H. S., and Oliveira, B., 1970, The biologic activities of guinea pig antibodies. II. Modes of complement interaction with 7I and 72 immunoglobulins, J. Immunol. 104: 329.PubMedGoogle Scholar
  98. Schluederberg, A., Ajello, C., and Evans, B., 1976, Fate of rubella genome ribonucleic acid after immune and nonimmune virolysis in the presence of ribonuclease, Infect. Immun. 14: 1097.PubMedGoogle Scholar
  99. Schreiber, R. D., Pangburn, M. K., Lasavre, P. H., and Muller-Eberhard, H. J., 1978, Initiation of the alternative pathway of complement: Recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins, J. Exp. Med. 75: 3948.Google Scholar
  100. Sherwin, S. A., Benveniste, R. E., and Todaro, G. J., 1978, Complement mediated lysis of type-C virus: Effect of primate and human sera on various retroviruses, Int. J. Cancer 21: 6.PubMedGoogle Scholar
  101. Silverstein, S., 1970, Macrophages and viral immunity, Semin. Hematol. 7: 185.PubMedGoogle Scholar
  102. Simpson, R. W., and Hauser, R. E., 1966, Influence of lipids on the viral phenotype. I. Interactions of myxoviruses and their lipid constituents with phospholipases, Virology 30: 684.PubMedGoogle Scholar
  103. Stollar, V., 1975, Immune lysis of Sindbis virus, Virology 66: 620.PubMedGoogle Scholar
  104. Svehag, S.-E., 1968, Formation and dissociation of virus antibody complexes with special reference to the neutralization process, Prog. Med. Virol. 10: 1.PubMedGoogle Scholar
  105. Taniguchi, S., and Yoshino, K., 1965, Studies on the neutralization of herpes simplex virus. II. Analysis of complement as the antibody-potentiating factor, Virology 26: 54.PubMedGoogle Scholar
  106. Thiry, L., Clerc, J. C.-L., Content, J., and Tack, L., 1978, Factors which influence inactivation of vesicular stomatitis virus by fresh human serum, Virology 87: 384.PubMedGoogle Scholar
  107. Todaro, G. J., Sherr, C. J., and Benveniste, R. E., 1976, Baboons and their close relatives are unusual among primates in their ability to release nondefective endogenous type C viruses, Virology 72: 278.PubMedGoogle Scholar
  108. Toussaint, A. J., and Muschel, L. H., 1962, Studies on the bacteriophage neutralizating activity of serums. I. An assay procedure for normal antibody and complement, J. Immunol 89: 27.PubMedGoogle Scholar
  109. Wallis, C., and Melnick, J. L., 1971, Herpesvirus neutralization: The role of complement, J. Immunol. 107: 1235.PubMedGoogle Scholar
  110. Wedgwood, R. J., Ginsberg, H. S., and Pillemer, L., 1956, The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system, J. Exp. Med. 104: 107.Google Scholar
  111. Welsh, R. M., Jr., 1977, Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement, J. Immunol. 118: 348.PubMedGoogle Scholar
  112. Welsh, R. M., Jr., Cooper, N. R., Jensen, F. C., and Oldstone, M. B. A., 1975, Human serum lyses RNA tumour viruses, Nature (London) 257: 612.Google Scholar
  113. Welsh, R. M., Cooper, N. R., Jensen, F. C., and Oldstone, M. B. A., 1976a, Inactivation and lysis of oncornaviruses by human serum, Virology 74: 432.PubMedGoogle Scholar
  114. Welsh, R. M., Jr., Lampert, P. W., Burner, P. A., and Oldstone, M. B. A., 19766, Antibody complement interactions with purified lymphocytic choriomeningitis virus, Virology 73: 59.Google Scholar
  115. Westaway, E. G., 1965, The neutralization of arboviruses. I. Neutralization in homologous virus-serum mixtures with two group B arboviruses, Virology 26: 517.PubMedGoogle Scholar
  116. Wheelock, E. F., and Toy, S. T., 1973, Participation of lymphocytes in viral infections, Adv. Immunol. 16: 123.PubMedGoogle Scholar
  117. Whitman, L., 1947, The neutralization of western equine encephalomyelitis virus by human convalescent serum: The influence of heat labile substances in serum on the neutralization index, J. Immunol. 56: 97.PubMedGoogle Scholar
  118. Wilson, G. S., and Miles, A., 1975, Principles of Bacteriology and Immunity, Vol. II, p. 1438, Williams and Wilkins, Baltimore.Google Scholar
  119. Yoshino, K., and Taniguchi, S., 1965, Studies on the neutralization of herpes simplex virus. I. Appearance of neutralizing antibodies having different grades of complement requirement, Virology 26: 44.PubMedGoogle Scholar
  120. Yoshino, K., and Taniguchi, S., 1969, Effect of complement upon viral neutralization, J. Immunol. 102: 1341.Google Scholar
  121. Zinkernagel, R. M., and Welsh, R. M., 1976, H-2 compatibility requirement for virus- specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D, J. Immunol. 117: 1495.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • Neil R. Cooper
    • 1
  1. 1.Department of Molecular ImmunologyScripps Clinic and Research FoundationLa JollaUSA

Personalised recommendations